NovoCure (NVCR) executive compensation, 2026 proxy

Frank Leonard, Chief Executive Officer, was paid $7M in 2025, up 20% from $5.8M the year before. The CEO-to-median-employee pay ratio was 84:1, on median employee pay of $148,799.

Filed
April 20, 2026
Annual meeting
June 3, 2026
Pay year
2025
Named executives
6
CEO total pay
$7M+20% vs prior year
CEO to median employee
84:1median $148,799
CEO pay in equity
86%$6M in awards
Prior say-on-pay support
98%of votes cast
Median Employee Pay
$148,799United Kingdom based full-time employee
Say-on-Pay Support
97.5%At 2025 annual meeting
Active Patients
4,620As of December 31, 2025
Total Prescriptions
7,035Received in 2025

How Leonard was paid

$7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary8%Stock awards72%Option awards14%Non-equity incentive6%All other compensation0%

Named executive officers

ExecutiveTotal
Frank LeonardChief Executive Officer$6,975,329
Ashley CordovaFormer Chief Executive Officer$13,198,354
Christoph BrackmannChief Financial Officer$4,163,398
Nicholas LeupinFormer Chief Medical Officer$3,999,041
Michael PuriChief Human Resources Officer$3,933,893
Uri WeinbergChief Medical and Innovation Officer$4,159,945

What changed and why

  • Frank Leonard became Chief Executive Officer on December 1, 2025, succeeding Ashley Cordova who resigned on November 30, 2025.
  • $7MFrank Leonard received total compensation of $6,975,329 for fiscal 2025 compared to $5,823,930 in the prior year.
  • $13.2MAshley Cordova received total compensation of $13,198,354 for fiscal 2025, which included amounts related to share and option awards expensed upon her resignation.
  • $12.5MThe pay ratio of the CEO to the median employee was 84 to 1 based on an annualized CEO compensation of $12,501,658.
  • 97.5%Shareholders expressed strong support for executive compensation with 97.5% of votes cast in favor at the 2025 annual meeting.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.